Investor · Cambridge, MA

Vinzenz P. Ploerer

Open Vinzenz in the network graph →

Filings

14

SEC Form D

Connections

119

co-filers

Capital

$54.7M

across filings

Active

May 2015

to May 2020

Most-connected co-filers (119)

David P. Madden · Cambridge, MA6 shared George P. Vlasuk · Cambridge, MA5 shared Donald E. Conrad · Islandia, NY4 shared Rick P. Lundberg · Cambridge, MA4 shared Alan Crane · MEDFORD, MA4 shared William Manby · Akron, OH4 shared Aaron Katz · New York, NY4 shared Stephen Richmond · Warsaw, R94 shared Marian Nakada · Cambridge, MA4 shared Pawel Gierynski · Warsaw, R94 shared Jonathan Neiss · NEW YORK, NY4 shared Oranee Daniels · BRISBANE, CA3 shared Thomas L. Tuttle · New York, NY3 shared Kevin Bitterman · Cambridge, MA3 shared David Icikson · New York, NY3 shared Blanche M. Johnson · Rockville, MD3 shared John Creecy · Boulder, CO3 shared Neil Milne · Warsaw, R93 shared Gail J. Maderis · Emeryville, CA3 shared Catenary Carbon GP, LLC · Miami, FL3 shared Ekta S. Dang · Fremont, CA3 shared Brenda Smith · Conshohocken, PA3 shared Seth Lax · NEW YORK, NY3 shared Tullis Growth Partners Ii, L.L.C · PALM BEACH GARDENS, FL3 shared

Recent filings (14)

Antiva Biosciences, Inc.Nov 2021 · 28 co-filers$31.0M Antiva Biosciences, Inc.Nov 2021 · 28 co-filers$31.0M Navitor Pharmaceuticals, Inc.May 2020 · 27 co-filers$20.2M Navitor Pharmaceuticals, Inc.Jan 2019 · 29 co-filers$11.3M Antiva Biosciences, Inc.Jul 2018 · 14 co-filers$15.0M Navitor Pharmaceuticals, Inc.Mar 2018 · 27 co-filers$25.0M Geno LLCSep 2017 · 10 co-filers$35.1M Antiva Biosciences, Inc.Apr 2017 · 25 co-filers$22.3M Therabron Therapeutics, Inc.Dec 2016 · 13 co-filers$6.0M Therabron Therapeutics, Inc.Dec 2016 · 13 co-filers$6.0M TYROGENEX, INC.Feb 2016 · 17 co-filers$12.0M TYROGENEX, INC.Feb 2016 · 17 co-filers$12.0M Navitor Pharmaceuticals, Inc.Dec 2015 · 25 co-filers$33.3M Therabron Therapeutics, Inc.Nov 2015 · 11 co-filers$6.7M Therabron Therapeutics, Inc.Nov 2015 · 11 co-filers$6.7M Profility, Inc.May 2015 · 12 co-filers$1.8M Profility, Inc.May 2015 · 14 co-filers$1.8M Clarassance, Inc.Jun 2014 · 5 co-filers$7.2M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Vinzenz in the interactive graph →